VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ILMNIllumina, Inc.
$176.55$26.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksILMNBalance Sheet

Illumina, Inc. (ILMN) Balance Sheet

27Y historyFree accessUpdated daily

The company has significantly improved its financial position, reducing its debt-to-equity ratio from a peak of 2.03 in 2024Q2 to 0.81 in 2026Q1 as it unwinds capital-intensive legacy acquisitions.

ILMN Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Jan'23Jan'22Jan'21Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Total Current Assets2.74B3.29B2.75B2.61B3.56B2.71B4.48B4.45B4.49B2.98B2.32B2.1B1.89B1.62B1.79B1.54B1.26B981.59M864.94M562.75M193.73M79.71M83.69M40.42M72.82M96.26M129.07M33.49M
Cash & Short-Term Investments1.16B1.63B1.22B1.05B2.04B1.34B3.47B3.41B3.51B2.15B1.56B1.39B1.34B1.17B1.35B1.19B894.29M693.53M640.08M386.08M130.8M50.82M54.79M32.78M53.76M90.49M117.1M33.09M
Cash Only1.09B1.42B1.13B1.05B2.01B1.23B1.81B2.04B1.14B1.23B734.52M768.77M636.15M711.64M433.98M302.98M248.95M144.63M327.02M174.94M38.39M50.82M54.79M12.46M2.04M4.17M116.1M21.16M
Short-Term Investments66M215M93M6M26M107M1.66B1.37B2.37B920M824.21M617.45M702.22M453.97M916.22M886.59M645.34M548.89M313.05M211.14M92.42M0020.32M51.73M86.33M1M11.92M
Accounts Receivable738M854M751M752M688M664M487M573M514M411M381.32M385.53M289.46M238.95M214.97M173.89M165.6M157.75M133.27M83.12M39.98M17.62M11.89M4.8M3.73M1.27M0308.94K
Days Sales Outstanding63.5771.8662.760.9454.7853.5554.8859.0356.2954.5158.0363.3956.7661.3768.3260.1366.9686.4184.8682.7179.0687.585.862.47135.64185.88-237.88
Inventory611M564M547M587M568M431M372M359M386M333M300.17M270.78M191.14M154.1M158.72M128.78M142.21M92.78M73.43M53.98M20.17M10.31M3.81M2.02M2.3M971K00
Days Inventory Outstanding147.97142.46132.13121.74128.61114.66131.06121.78136.39131.26149.67147.29123.78110.44154.49135.68172.33164.57130.35148.77124.05162.32104.873.53237.31636.29--
Other Current Assets234M238M228M216M268M0152M105M78M91M77.88M54.3M70.63M58.89M30.45M52.38M56.3M20.02M18.16M26.93M2.77M959K999K100K12.53M3.29M11.96M95.83K
Total Non-Current Assets3.82B3.35B3.56B7.5B8.69B12.5B3.1B2.87B2.47B2.28B1.96B1.59B1.45B1.4B779.04M651.22M580.72M448.35M512.16M424.98M106.86M20.9M11.22M58.82M49.09M26.2M3.73M401.61K
Property, Plant & Equipment1.13B1.13B1.23B1.55B1.74B1.7B1.45B1.44B1.07B931M713.33M342.69M265.26M202.67M166.17M143.48M129.87M117.19M89.44M46.27M25.63M16.13M8.57M45.78M48.28M25.97M3.29M291.31K
Fixed Asset Turnover3.86x3.84x3.54x2.90x2.63x2.67x2.23x2.45x3.10x2.96x3.36x6.48x7.02x7.01x6.91x7.36x6.95x5.69x6.41x7.93x7.20x4.56x5.90x0.61x0.21x0.10x0.40x1.63x
Goodwill1.28B1.11B1.11B2.54B3.24B7.11B897M824M831M771M776M752.63M724.9M723.06M369.33M321.85M278.21M213.45M228.73M228.73M2.13M2.13M000000
Intangible Assets430M210M295M2.99B3.29B3.25B142M145M185M175M242.65M273.62M314.5M331.17M130.2M106.47M70.02M43.79M47.76M57.97M108K59K11.89M848K786K037.87K75.73K
Long-Term Investments598M0227M196M211M213M418M283M260M266M57.4M56.6M37.2M22.1M045.3M32M055.9M067.78M0012.19M0-29K00
Other Non-Current Assets523M449M121M217M212M232M171M105M48M46M49.81M30.86M58.32M33.99M73.16M14.44M31.11M26.55M12.02M11.75M11.21M2.58M012.19M22K262K398.77K34.57K
Total Assets6.56B6.64B6.3B10.11B12.25B15.22B7.58B7.32B6.96B5.26B4.28B3.69B3.34B3.02B2.57B2.2B1.84B1.43B1.38B987.73M300.58M100.61M94.91M99.23M121.91M122.47M132.79M33.89M
Asset Turnover0.69x0.65x0.69x0.45x0.37x0.30x0.43x0.48x0.48x0.52x0.56x0.60x0.56x0.47x0.45x0.48x0.49x0.47x0.42x0.37x0.61x0.73x0.53x0.28x0.08x0.02x0.01x0.01x
Asset Growth %14.32%5.41%-37.66%-17.47%-19.48%100.62%3.68%5.13%32.38%22.81%16.08%10.5%10.55%17.65%16.86%19.4%28.62%3.84%39.42%228.6%198.76%6.01%-4.36%-18.6%-0.46%-7.78%291.78%-
Total Current Liabilities1.57B1.58B1.55B1.57B2.77B1.09B1.24B665M1.8B746M704.66M610.49M722.16M322.06M304.57M237.58M534.52M441.24M509.56M165.72M33.78M21.72M19.05M8.19M14.3M4.81M2.81M612.41K
Accounts Payable218M240M221M245M293M332M192M149M184M160M138M139.23M82.63M73.66M65.73M49.81M66.74M52.78M29.2M24.31M9.85M7.39M2.68M7.57M1.77M1.98M727K318.22K
Days Payables Outstanding55.460.6253.3950.8166.3488.3267.6450.5465.0163.0768.8175.7353.5152.7963.9852.4780.8893.6251.846760.6116.3673.89275.29182.711.29K-666.72-1.21K
Short-Term Debt499M499M578M01.25B0562M45M1.11B10M1.25M74.93M304.26M29.29M36.97M0311.61M290.2M400M16K63K118K0619K677K297K261K1.5K
Deferred Revenue (Current)751M270M260M252M245M234M186M167M175M130M120.62M96.65M75.29M50.83M69.58M52.57M45.86M015.86M7.54M000010.01M10.05M00
Other Current Liabilities849M249M70M223M188M241M83M64M63M219M301.02M134.86M108.43M55.15M70M53.17M47.66M024.71M90.54M13.82M8.35M11.64M-5.54M001.82M292.69K
Current Ratio1.75x2.08x1.78x1.66x1.28x2.48x3.60x6.69x2.49x3.99x3.29x3.43x2.62x5.02x5.87x6.50x2.35x2.22x1.70x3.40x5.74x3.67x4.39x4.94x5.09x20.02x45.99x54.69x
Quick Ratio1.36x1.72x1.42x1.29x1.08x2.09x3.30x6.15x2.27x3.55x2.86x2.99x2.35x4.54x5.35x5.96x2.09x2.01x1.55x3.07x5.14x3.20x4.19x4.69x4.93x19.82x45.99x54.69x
Cash Conversion Cycle156.15153.7141.45131.87117.0579.89118.3130.27127.66122.7138.89134.95127.03119.02158.83143.34158.41157.36163.36164.48142.51133.46116.72-139.29190.24-472.04--
Total Non-Current Liabilities1.97B2.34B2.38B2.8B2.88B3.38B1.65B2.04B1.31B1.67B1.31B1.23B1.15B1.16B942.93M883.04M106.92M124.45M18.95M410.34M19.47M6.39M3.6M43.66M35.87M10.87M5.89M1.25M
Long-Term Debt1.97B1.49B1.49B1.49B1.49B1.7B673M1.14B890M1.18B1.05B1.02B986.78M839.59M805.41M813.09M78.39M00400M054K025M25.37M590K886.63K0
Capital Lease Obligations1.52B486M554M687M744M774M671M695M269M0000000000000000000
Deferred Tax Liabilities0000000000000000047.37M080.25M6.99M0000000
Other Non-Current Liabilities0360M272M620M649M915M259M160M359M360M213.95M180.5M167.9M324.15M137.53M80.61M28.53M77.08M16.63M10.34M10.01M3.5M379K18.66M10.5M10.28M5M1.25M
Total Liabilities3.53B3.92B3.93B4.37B5.65B4.48B2.89B2.7B3.05B2.29B1.97B1.81B1.88B1.49B1.25B1.12B641.44M565.69M528.5M576.05M53.24M28.11M22.64M51.85M50.16M15.67M8.69M1.86M
Total Debt2.46B2.55B2.62B2.26B3.56B2.54B1.91B1.88B2B1.19B1.05B1.09B1.29B868.88M842.37M813.09M390M290.2M400M400.02M63K172K025.62M26.3M887K1.15M1.5K
Net Debt1.38B1.14B1.5B1.21B1.54B1.31B96M-161M853M-33M314.54M321.81M654.88M157.24M408.39M510.11M141.05M145.57M72.97M225.07M-38.32M-50.65M-66.99M13.15M24.26M-3.28M-114.95M-21.16M
Debt / Equity0.81x0.94x1.10x0.39x0.54x0.24x0.41x0.41x0.51x0.39x0.45x0.58x0.88x0.57x0.64x0.76x0.33x0.34x0.47x0.97x0.00x0.00x-0.54x0.37x0.01x0.01x0.00x
Debt / EBITDA2.20x2.25x---19.84x2.49x1.60x1.88x1.56x1.44x1.47x2.06x3.74x3.17x3.03x1.54x1.85x3.70x-0.00x-------
Net Debt / EBITDA1.23x1.00x---10.22x0.13x-0.14x0.80x-0.04x0.43x0.43x1.04x0.68x1.53x1.90x0.56x0.93x0.67x--0.88x-------
Interest Coverage12.09x8.55x-10.79x-13.51x-165.77x15.49x18.47x22.50x16.68x29.19x18.00x14.56x11.75x5.01x6.89x4.82x8.54x5.81x4.27x---------
Total Equity3.03B2.72B2.37B5.75B6.6B10.74B4.69B4.61B3.93B3.06B2.34B1.88B1.46B1.53B1.32B1.08B1.2B864.25M848.6M411.68M247.34M72.5M72.26M47.39M71.74M106.79M124.1M32.03M
Equity Growth %111.91%14.75%-58.69%-12.94%-38.56%128.8%1.76%17.32%28.33%30.76%24.57%28.6%-4.59%16.28%22.63%-10.22%38.58%1.84%106.13%66.44%241.18%0.33%52.49%-33.95%-32.82%-13.95%287.42%-
Book Value per Share19.6617.4614.9236.3642.0371.1331.7230.9626.3920.7015.8312.629.8210.969.867.748.356.306.353.802.540.901.010.741.161.792.2311.36
Total Shareholders' Equity3.03B2.72B2.37B5.75B6.6B10.74B4.69B4.61B3.85B2.84B2.27B1.85B1.46B1.53B1.32B1.08B1.2B864.25M848.6M411.68M247.34M72.5M72.26M47.39M71.74M106.79M124.1M32.03M
Common Stock02M2M2M2M2M2M2M2M2M1.89M1.86M1.8M1.75M1.7M1.67M1.52M1.44M1.39M628K469K413K381K329K325K322K319.65K51.39K
Retained Earnings0-392M-1.24B-19M1.14B5.49B4.72B4.07B3.08B2.26B1.49B1.02B561.21M207.85M82.55M-68.71M-155.34M-280.23M-332.5M-382.98M-104.62M-144.59M-123.71M-117.49M-90.42M-50.09M-25.27M-6.66M
Treasury Stock0-4.7B-3.93B-3.79B-3.75B-3.7B-3.85B-3.02B-2.62B-2.34B-2.02B-1.67B-1.27B-1.24B-1.19B-1.11B-541.56M-497.54M-322.41M-251.62M00000000
Accumulated OCI0-10M22M-1M3M17M2M5M-1M-1M-1.04M36K-1.08M1.23M2.12M2.12M1.76M2.83M2.41M1.35M11.29M-96K-60K-768K-2.64M-7.33M-14.03M-4.04M
Minority Interest0000000087M220M73.01M32.55M0000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowImproving
Top Statement Risk

Divestiture and leverage overhang

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Stabilizing Balance Sheet Post-Divestiture

As reported in recent financial statements, Illumina's total assets have contracted from $10.1 billion in 2023Q4 to $6.6 billion in 2026Q1, reflecting a significant reduction in balance sheet bloat as the company unwinds the capital-intensive GRAIL acquisition and refocuses on its core sequencing operations.

The reduction in total assets suggests a strategic pivot toward a leaner operational footprint, which may improve long-term capital efficiency. Investors should monitor whether this contraction in asset base leads to a more sustainable return on invested capital as the company sheds non-core, loss-making segments.

Leverage Normalization Following Strategic Shift

Based on the provided quarterly data, Illumina's debt-to-equity ratio has improved from a peak of 2.03 in 2024Q2 to 0.81 in 2026Q1, indicating that management is actively deleveraging the balance sheet to restore financial flexibility after the period of intense capital allocation volatility.

The current debt level appears manageable, though the reliance on debt to fund past strategic missteps warrants ongoing scrutiny of interest coverage ratios. The trend toward lower leverage suggests a shift in management priority toward balance sheet repair, which may reduce the risk profile for long-term equity holders.

Equity Base Recovering From Impairments

According to financial filings, Illumina's equity base has shown signs of stabilization, moving from a low of $1.4 billion in 2024Q2 to $3.0 billion in 2026Q1, primarily driven by the cessation of massive impairment charges associated with the GRAIL divestiture process.

The recovery in equity suggests that the most significant accounting impacts of the failed acquisition are likely behind the company. However, the persistent negative retained earnings balance indicates that the company is still working to rebuild its book value after years of aggressive, value-destructive capital deployment.

Liquidity Buffer Supporting Operational Needs

As reported in recent quarterly filings, Illumina maintains a current ratio of 1.75 as of 2026Q1, providing a sufficient liquidity buffer to support ongoing R&D and manufacturing requirements while navigating the competitive pressures within the high-throughput sequencing market.

The current liquidity position appears adequate to cover near-term obligations, though the fluctuation in cash balances suggests that working capital management remains sensitive to the timing of large-scale instrument placements. Maintaining this liquidity is critical for the company to defend its market share against emerging low-cost competitors.

ILMN — Frequently Asked Questions

Quick answers to the most common questions about buying ILMN stock.

What are the total assets of Illumina, Inc. (ILMN)?

As of 2025, Illumina, Inc. (ILMN) had total assets of $6.64B including $3.29B in current assets.

How much debt does Illumina, Inc. (ILMN) have?

Illumina, Inc. (ILMN) carries total debt of $2.55B, offset by $1.63B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Illumina, Inc.?

Illumina, Inc. (ILMN) has total shareholders' equity (book value) of $2.72B ($17.46 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Illumina, Inc.'s current ratio and liquidity?

Illumina, Inc. (ILMN) reported a current ratio of 2.08x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.